{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:31:57Z","timestamp":1791480717182,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Visual problems are common among persons with multiple sclerosis (MS) and may interfere with the assessment of cognitive functioning using visually mediated neuropsychological tests. The current study explored visual discomfort symptoms among persons with MS compared to healthy controls (HCs), using the Visual Discomfort Scale (VDS), which measures somatic and perceptual visual discomfort symptoms that interfere with reading.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighty-nine persons with MS and 30 HCs completed the VDS and the Symbol Digit Modalities Test (SDMT), a visually mediated test of information processing speed and gold standard for screening for MS-related cognitive dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Persons with MS endorsed higher frequencies of visual discomfort symptoms, including seeing the text or background moving or fading, headache\/eye soreness, blurriness\/diplopia, having to re-read, and slow reading, compared to HCs. More frequent visual discomfort symptoms were associated with worse performance on the SDMT. For participants with MS reporting moderate\/high levels of visual discomfort symptoms, having a longer disease duration or progressive disease courses were correlated with worse performance on the SDMT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>It is important for clinicians to ask about specific visual discomfort problems that the patient experiences when interpreting a visually-mediated neuropsychological test such as the SDMT, especially for MS patients with longer disease duration or a progressive disease course.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1569451","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:23:52Z","timestamp":1750051432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of visual discomfort symptoms on SDMT performance among persons with MS"],"prefix":"10.3389","volume":"16","author":[{"given":"Michelle H.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Chiaravalloti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Goverover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana L.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/134858","article-title":"The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis","volume":"2013","author":"Costello","year":"2013","journal-title":"ISRN Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1177\/1352458513479840","article-title":"Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability","volume":"19","author":"Jasse","year":"2013","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awu335","article-title":"Vision and vision-related outcome measures in multiple sclerosis","volume":"138","author":"Balcer","year":"2015","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0002-9394(02)01337-5","article-title":"Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire","volume":"133","author":"Ma","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity","volume":"80","author":"Mowry","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ajo.2006.04.051","article-title":"Utility of the National eye Institute VFQ-25 questionnaire in a heterogeneous Group of Multiple Sclerosis Patients","volume":"142","author":"Noble","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/135245850000600604","article-title":"Self-reported visual dysfunction in multiple sclerosis: results from the 25-item National eye Institute visual function questionnaire (VFQ-25)","volume":"6","author":"Balcer","year":"2000","journal-title":"Mult Scler"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ajo.2006.06.060","article-title":"Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25","volume":"142","author":"Raphael","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/135062899394885","article-title":"Measuring visual discomfort","volume":"6","author":"Conlon","year":"1999","journal-title":"Vis Cogn"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/OPX.0b013e31812f5f51","article-title":"Measuring visual discomfort in college students","volume":"84","author":"Borsting","year":"2007","journal-title":"Optom Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis.: I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10072-010-0438-7","article-title":"Treatment options of cognitive impairment in multiple sclerosis","volume":"31","author":"Patti","year":"2010","journal-title":"Neurol Sci"},{"key":"ref16","article-title":"Cognitive function and quality of life in multiple sclerosis patients","author":"Cutajar","year":"","journal-title":"Journal of Neurovirology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.18502\/cjn.v21i3.11106","article-title":"Association of cognitive impairment and quality of life in patients with multiple sclerosis: a cross-sectional study","volume":"21","author":"Nabizadeh","year":"2022","journal-title":"CJN"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00415-012-6705-1","article-title":"Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study","volume":"260","author":"Ruet","year":"2013","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e00875","DOI":"10.1002\/brb3.875","article-title":"Progressive multiple sclerosis, cognitive function, and quality of life","volume":"8","author":"Chow","year":"2018","journal-title":"Brain Behav"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2009.11.004","article-title":"The association between cognitive impairment and quality of life in patients with early multiple sclerosis","volume":"290","author":"Glanz","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2377-11-17","article-title":"Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study","volume":"11","author":"Baumstarck-Barrau","year":"2011","journal-title":"BMC Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"102436","DOI":"10.1016\/j.msard.2020.102436","article-title":"Visual and motor confounds on the symbol digit modalities test","volume":"45","author":"Chen","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/WNO.0000000000000272","article-title":"Neuro-ophthalmic syndromes and processing speed in multiple sclerosis","volume":"36","author":"Costa","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458518803785","article-title":"Recommendations for cognitive screening and management in multiple sclerosis care","volume":"24","author":"Kalb","year":"2018","journal-title":"Mult Scler"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1017\/S1355617707070658","article-title":"Mild visual acuity disturbances are associated with performance on tests of complex visual attention in MS","volume":"13","author":"Bruce","year":"2007","journal-title":"J Inter Neuropsych Soc"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/13854046.2011.565075","article-title":"Visual acuity is associated with performance on visual and non-visual neuropsychological tests in multiple sclerosis","volume":"25","author":"Feaster","year":"2011","journal-title":"Clin Neuropsychol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2377-13-167","article-title":"Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study","volume":"13","author":"Wieder","year":"2013","journal-title":"BMC Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458518808204","article-title":"Symbol digit modalities test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis","volume":"25","author":"Strober","year":"2019","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","article-title":"Minimal neuropsychological assessment of MS patients: a consensus approach","volume":"16","author":"Benedict","year":"2002","journal-title":"Clin Neuropsychol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","article-title":"Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS)","volume":"18","author":"Langdon","year":"2012","journal-title":"Mult Scler"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National eye Institute visual function questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00415-024-12797-0","article-title":"Unraveling the inflammation\u2013degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer","volume":"272","author":"Zangh\u00ec","year":"2025","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.msard.2018.03.007","article-title":"Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: a review","volume":"22","author":"Alonso","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/13524585241304356","article-title":"Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis","volume":"31","author":"Christensen","year":"2025","journal-title":"Mult Scler"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/WNO.0000000000001326","article-title":"Optical coherence tomography is associated with cognitive impairment in multiple sclerosis","volume":"42","author":"Dreyer-Alster","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00415-022-11449-5","article-title":"Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis","volume":"270","author":"Mirmosayyeb","year":"2023","journal-title":"J Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/antiox10050700","article-title":"Dietary phenolic acids and their major food sources are associated with cognitive status in older Italian adults","volume":"10","author":"Godos","year":"2021","journal-title":"Antioxidants"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/nu12092862","article-title":"Dietary patterns, carbohydrates, and age-related eye diseases","volume":"12","author":"Francisco","year":"2020","journal-title":"Nutrients"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1569451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:23:53Z","timestamp":1750051433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1569451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":39,"alternative-id":["10.3389\/fneur.2025.1569451"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1569451","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1569451"}}